GOLDENWELL BIOTECH, INC. (GWLL) Total liabilities 2019–2025
GOLDENWELL BIOTECH, INC. (GWLL) total liabilities at each fiscal year-end, per SEC filings.
$379,833FY2025 · since FY2019: $0 → $379,833
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $379,833 | +39.9% |
| FY2024 | $271,433 | +88.7% |
| FY2023 | $143,837 | +207.5% |
| FY2022 | $46,782 | -70.6% |
| FY2021 | $159,266 | — |
| FY2020 | $0 | — |
| FY2019 | $0 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More GWLL financial trends
GWLL RevenueGWLL Net incomeGWLL Net marginGWLL Gross profitGWLL Gross marginGWLL Operating incomeGWLL Operating marginGWLL Operating cash flowGWLL Free cash flowGWLL Capital expendituresGWLL Return on equityGWLL Stock buybacksGWLL Dividends paidGWLL Total assetsGWLL Shareholders’ equityGWLL overview →